Sort
21,453 grants matching “tuberculosis”
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,349,582Joseph M Fox · University Of Delaware · P20 · FY2020 · GM
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,344,199Dartmouth College · P20 · FY2003 · RR
Pathway Analysis in Tuberculosis
$2,344,044Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · AI
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,343,963Dartmouth College · P20 · FY2004 · RR
Rapid Tests for Drug Resistance to Detect Extensively Drug-Resistant Tuberculosis
$2,342,929Antonino None Catanzaro · University Of California, San Diego · U01 · FY2011 · AI
Safety Evaluation of Anti-Infective Agents
$2,342,006Jon Carl Mirsalis · Sri International · N01 · FY2012 · AI
Human monoclonal antibodies targeting infectious pathogens
$2,338,839Joshua Tan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
IeDEA Asia-Pacific Research Collaboration
$2,338,493Annette H Sohn · Foundation For Aids Research · U01 · FY2020 · AI
A Proteomics Research Center for Integrative Biology
$2,337,477Richard D Smith · Battelle Pacific Northwest Laboratories · P41 · FY2016 · GM
The Asia-Pacific HIV Research Collaboration
$2,336,518David A Cooper · Foundation For Aids Research · U01 · FY2013 · AI
Optimizing Combination Therapy to Accelerate Clinical Cure of Tuberculosis
$2,336,318George Louis Drusano · University Of Florida · P01 · FY2016 · AI
Mycobacterium avium complex pulmonary infection: immunologic and transcriptomic signatures of disease and treatment response
$2,335,860Kevin Loring Winthrop · Oregon Health & Science University · R01 · FY2025 · AI
The intersection of innate and adaptive immunity to intracellular pathogens
$2,333,166Daniel A Portnoy · University Of California Berkeley · P01 · FY2022 · AI
Optimizing Combination Therapy to Accelerate Clinical Cure of Tuberculosis
$2,332,983George Louis Drusano · University Of Florida · P01 · FY2018 · AI
Chemical detection of Mycobacterium tuberculosis growth and antibiotic response during infection
$2,330,466Mary Sloan Siegrist · University Of Massachusetts Amherst · DP2 · FY2017 · AI
NORTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$2,329,815Northwestern University · U01 · FY2004 · AI
Determinants of TB control, relapse and reinfection
$2,329,771Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2025 · AI
PERU Clinical Trial Unit
$2,328,404Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2025 · AI
BUILDING GLOBAL CAPACITY FOR DIAGNOSTIC TESTING OF TUBERCULOSIS, MALARIA AND HIV
$2,328,395Heidi Albert · Foundation/Innovative New Diagnostics · U2G · FY2014 · PS
Metabolic determinants of Mtb virulence, vulnerability and variation
$2,327,403David Branch Moody · Brigham And Women'S Hospital · U19 · FY2025 · AI
The intersection of innate and adaptive immunity to intracellular pathogens
$2,325,406Daniel A Portnoy · University Of California Berkeley · P01 · FY2024 · AI
The intersection of innate and adaptive immunity to intracellular pathogens
$2,325,406Daniel A Portnoy · University Of California Berkeley · P01 · FY2025 · AI
The intersection of innate and adaptive immunity to intracellular pathogens
$2,325,406Daniel A Portnoy · University Of California Berkeley · P01 · FY2023 · AI
DNA Replication, Repair, and Mutagenesis In Eukaryotic And Prokaryotic Cells
$2,325,386Roger Woodgate · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
SciBay: A New Methodology for Scientific Collaboration and Gene Function Determi
$2,323,184Martin A Steffen · Boston University (Charles River Campus) · RC2 · FY2009 · GM